Prevention of Barrett Esophagus and Esophageal Adenocarcinoma by Smoothened Inhibitor in a Rat Model of Gastroesophageal Reflux Disease

Advances in targeting the Hedgehog signaling pathway in cancer therapy

(2012) Tobias Kiesslich et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Identification of Signature Genes for Detecting Hedgehog Pathway Activation in Esophageal Cancer

(2011) Ling Yang et al.   PATHOLOGY & ONCOLOGY RESEARCH

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in High-Grade Dysplasia and Adenocarcinoma of the Esophagus and May Represent a Biomarker of Histological Progression in Barrett's Esophagus (BE)

(2010) James Cronin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

(2010) Stefan Peukert et al.   ChemMedChem

Rabeprazole Impedes the Development of Reflux-Induced Esophageal Cancer in a Surgical Rat Model

(2010) Tomoharu Miyashita et al.   DIGESTIVE DISEASES AND SCIENCES

Aberrant Epithelial–Mesenchymal Hedgehog Signaling Characterizes Barrett's Metaplasia

(2010) David H. Wang et al.   GASTROENTEROLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Review: Targeting the Hedgehog pathway in cancer

(2010) Sachin Gupta et al.   Therapeutic Advances in Medical Oncology

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling

(2008) Daniel S. Oh et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES